Evidence map›Paper›PMID 37815702›Full record

ArticlePhysical and engineering sciences in medicine2023

Determination of acceptable Hounsfield units uncertainties via a sensitivity analysis for an accurate dose calculation in the context of prostate MRI-only radiotherapy.

Hilda Chourak, Anaïs Barateau, Peter Greer, Caroline Lafond, Jean-Claude Nunes, Renaud de Crevoisier, Jason Dowling, Oscar Acosta

Abstract read
In one paragraph

Article in Physical and engineering sciences in medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hilda ChourakUniv Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, France. hilda.chourak@univ-rennes.fr.ORCID http://orcid.org/0000-0002-7186-5568
Anaïs BarateauUniv Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, France.
Peter GreerSchool of Mathematical and Physical Sciences, University of Newcastle, Newcastle, NSW, Australia.
Caroline LafondUniv Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, France.
Jean-Claude NunesUniv Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, France.
Renaud de CrevoisierUniv Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, France.
Jason DowlingCSIRO Australian e-Health Research Centre, Herston, QLD, Australia. jason.dowling@csiro.au.
Oscar AcostaUniv Rennes, CLCC Eugène Marquis, INSERM, LTSI - UMR 1099, Rennes, France.

Funding

Australian e-Health Research Centre Australian e-Health Research CentreRégion Bretagne Région Bretagne
6 · The paper itself

Abstract

Radiation therapy is moving from CT based to MRI guided planning, particularly for soft tissue anatomy. An important requirement of this new workflow is the generation of synthetic-CT (sCT) from MRI to enable treatment dose calculations. Automatic methods to determine the acceptable range of CT Hounsfield Unit (HU) uncertainties to avoid dose distribution errors is thus a key step toward safe MRI-only radiotherapy. This work has analysed the effects of controlled errors introduced in CT scans on the delivered radiation dose for prostate cancer patients. Spearman correlation coefficient has been computed, and a global sensitivity analysis performed following the Morris screening method. This allows the classification of different error factors according to their impact on the dose at the isocentre. sCT HU estimation errors in the bladder appeared to be the least influential factor, and sCT quality assessment should not only focus on organs surrounding the radiation target, as errors in other soft tissue may significantly impact the dose in the target volume. This methodology links dose and intensity-based metrics, and is the first step to define a threshold of acceptability of HU uncertainties for accurate dose planning.

Indexed as

ProstateProstatic NeoplasmsHumansMagnetic Resonance ImagingMaleTomography, X-Ray ComputedUrinary BladderMRI-only radiotherapyProstate cancerQuality assuranceSensitivity analysisSynthetic-CT

Identifiers

PMID37815702
PMCPMC10703986

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.